COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 190 filers reported holding COHERUS BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,943,386 | +120.7% | 1,321,761 | +152.0% | 0.00% | – |
| Q2 2023 | $2,239,875 | -51.6% | 524,561 | -22.5% | 0.00% | -100.0% |
| Q1 2023 | $4,630,885 | -16.7% | 677,030 | -3.5% | 0.00% | 0.0% |
| Q4 2022 | $5,556,609 | -25.1% | 701,592 | -9.1% | 0.00% | -50.0% |
| Q3 2022 | $7,421,000 | +70.6% | 772,222 | +28.5% | 0.00% | +100.0% |
| Q2 2022 | $4,351,000 | -29.0% | 600,975 | +26.6% | 0.00% | 0.0% |
| Q1 2022 | $6,128,000 | -31.8% | 474,659 | -15.7% | 0.00% | -50.0% |
| Q4 2021 | $8,990,000 | -14.3% | 563,236 | -13.7% | 0.00% | 0.0% |
| Q3 2021 | $10,485,000 | +31.6% | 652,486 | +13.3% | 0.00% | 0.0% |
| Q2 2021 | $7,966,000 | -59.1% | 575,985 | -56.8% | 0.00% | -60.0% |
| Q1 2021 | $19,492,000 | -21.5% | 1,334,203 | -6.6% | 0.01% | -16.7% |
| Q4 2020 | $24,837,000 | -7.6% | 1,429,077 | -2.5% | 0.01% | -25.0% |
| Q3 2020 | $26,876,000 | +16.6% | 1,465,464 | +13.6% | 0.01% | +14.3% |
| Q2 2020 | $23,049,000 | -9.5% | 1,290,542 | -17.8% | 0.01% | -22.2% |
| Q1 2020 | $25,472,000 | -0.0% | 1,570,369 | +11.0% | 0.01% | +50.0% |
| Q4 2019 | $25,473,000 | +27.1% | 1,414,789 | +43.0% | 0.01% | 0.0% |
| Q3 2019 | $20,043,000 | +73.9% | 989,305 | +89.7% | 0.01% | +100.0% |
| Q2 2019 | $11,526,000 | +33.9% | 521,539 | -17.4% | 0.00% | 0.0% |
| Q1 2019 | $8,610,000 | +120.9% | 631,263 | +46.6% | 0.00% | +200.0% |
| Q4 2018 | $3,898,000 | -33.9% | 430,726 | +20.4% | 0.00% | -50.0% |
| Q3 2018 | $5,901,000 | +63.5% | 357,659 | +38.7% | 0.00% | +100.0% |
| Q2 2018 | $3,609,000 | -21.1% | 257,778 | -37.7% | 0.00% | 0.0% |
| Q1 2018 | $4,572,000 | +53.1% | 413,757 | +21.9% | 0.00% | 0.0% |
| Q4 2017 | $2,987,000 | +52.6% | 339,480 | +131.6% | 0.00% | – |
| Q3 2017 | $1,957,000 | -3.2% | 146,597 | +4.0% | 0.00% | -100.0% |
| Q2 2017 | $2,022,000 | -32.2% | 140,923 | -0.1% | 0.00% | 0.0% |
| Q1 2017 | $2,984,000 | +155.0% | 141,095 | +239.6% | 0.00% | – |
| Q4 2016 | $1,170,000 | +45.9% | 41,547 | +38.7% | 0.00% | – |
| Q3 2016 | $802,000 | +328.9% | 29,957 | +171.1% | 0.00% | – |
| Q2 2016 | $187,000 | -13.4% | 11,050 | +8.5% | 0.00% | – |
| Q1 2016 | $216,000 | +6.9% | 10,184 | +1.0% | 0.00% | – |
| Q3 2015 | $202,000 | -71.5% | 10,083 | -56.6% | 0.00% | – |
| Q1 2015 | $710,000 | – | 23,221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |